Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
658 | 3202 | 42.3 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
343 | 3 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE SYNTHASE | 36678 |
1338 | 2 | PHOSPHODIESTERASE//ROLIPRAM//PDE4 | 8346 |
658 | 1 | ROLIPRAM//PHOSPHODIESTERASE//PDE4 | 3202 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ROLIPRAM | authKW | 1231951 | 7% | 54% | 239 |
2 | PHOSPHODIESTERASE | authKW | 1019701 | 13% | 25% | 423 |
3 | PDE4 | authKW | 831173 | 4% | 69% | 127 |
4 | ROFLUMILAST | authKW | 578831 | 3% | 71% | 85 |
5 | PDE4 INHIBITOR | authKW | 556587 | 3% | 70% | 83 |
6 | PDE10A | authKW | 548429 | 2% | 91% | 63 |
7 | PHOSPHODIESTERASE 4 | authKW | 343181 | 2% | 55% | 66 |
8 | PHOSPHODIESTERASE 4 INHIBITOR | authKW | 252696 | 2% | 49% | 54 |
9 | PHOSPHODIESTERASE INHIBITORS | authKW | 218874 | 5% | 15% | 150 |
10 | PHOSPHODIESTERASE 10A | authKW | 193985 | 1% | 88% | 23 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 9398 | 33% | 0% | 1047 |
2 | Chemistry, Medicinal | 7024 | 14% | 0% | 461 |
3 | Biochemistry & Molecular Biology | 2302 | 25% | 0% | 814 |
4 | Respiratory System | 846 | 5% | 0% | 154 |
5 | Neurosciences | 727 | 11% | 0% | 359 |
6 | Chemistry, Organic | 428 | 7% | 0% | 220 |
7 | Cell Biology | 357 | 7% | 0% | 239 |
8 | Biophysics | 228 | 4% | 0% | 134 |
9 | Allergy | 169 | 1% | 0% | 41 |
10 | Immunology | 93 | 5% | 0% | 146 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOMETR PHARMACOKINET | 68098 | 0% | 71% | 10 |
2 | MOL PHARMACOL GRP | 61031 | 2% | 13% | 50 |
3 | PULM CRIT CARE MED BRANCH | 39312 | 1% | 13% | 32 |
4 | BEHAV MED PSYCHIAT | 36998 | 1% | 15% | 26 |
5 | SACKLER PULM PHARMACOL | 29783 | 1% | 12% | 27 |
6 | MATERNITE PORT ROYAL COCHIN | 28603 | 0% | 100% | 3 |
7 | TOXICOL PHARM CHEM | 28603 | 0% | 100% | 3 |
8 | SMALL MOL CHEM | 24510 | 0% | 43% | 6 |
9 | CNS DRUG DISCOVERY UNIT | 20859 | 0% | 24% | 9 |
10 | BIOCHEM INFLAMMAT | 19069 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH | 16055 | 1% | 8% | 20 |
2 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 15747 | 0% | 11% | 15 |
3 | CELLULAR SIGNALLING | 10935 | 2% | 2% | 71 |
4 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 9763 | 1% | 3% | 39 |
5 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 9675 | 0% | 9% | 11 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 9490 | 5% | 1% | 160 |
7 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 7774 | 0% | 12% | 7 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 5893 | 3% | 1% | 106 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4934 | 3% | 1% | 106 |
10 | EXPERT OPINION ON THERAPEUTIC PATENTS | 4333 | 1% | 1% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROLIPRAM | 1231951 | 7% | 54% | 239 | Search ROLIPRAM | Search ROLIPRAM |
2 | PHOSPHODIESTERASE | 1019701 | 13% | 25% | 423 | Search PHOSPHODIESTERASE | Search PHOSPHODIESTERASE |
3 | PDE4 | 831173 | 4% | 69% | 127 | Search PDE4 | Search PDE4 |
4 | ROFLUMILAST | 578831 | 3% | 71% | 85 | Search ROFLUMILAST | Search ROFLUMILAST |
5 | PDE4 INHIBITOR | 556587 | 3% | 70% | 83 | Search PDE4+INHIBITOR | Search PDE4+INHIBITOR |
6 | PDE10A | 548429 | 2% | 91% | 63 | Search PDE10A | Search PDE10A |
7 | PHOSPHODIESTERASE 4 | 343181 | 2% | 55% | 66 | Search PHOSPHODIESTERASE+4 | Search PHOSPHODIESTERASE+4 |
8 | PHOSPHODIESTERASE 4 INHIBITOR | 252696 | 2% | 49% | 54 | Search PHOSPHODIESTERASE+4+INHIBITOR | Search PHOSPHODIESTERASE+4+INHIBITOR |
9 | PHOSPHODIESTERASE INHIBITORS | 218874 | 5% | 15% | 150 | Search PHOSPHODIESTERASE+INHIBITORS | Search PHOSPHODIESTERASE+INHIBITORS |
10 | PHOSPHODIESTERASE 10A | 193985 | 1% | 88% | 23 | Search PHOSPHODIESTERASE+10A | Search PHOSPHODIESTERASE+10A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LUGNIER, C , (2006) CYCLIC NUCLEOTIDE PHOSPHODIESTERASE (PDE) SUPERFAMILY: A NEW TARGET FOR THE DEVELOPMENT OF SPECIFIC THERAPEUTIC AGENTS.PHARMACOLOGY & THERAPEUTICS. VOL. 109. ISSUE 3. P. 366-398 | 235 | 70% | 437 |
2 | BENDER, AT , BEAVO, JA , (2006) CYCLIC NUCLEOTIDE PHOSPHODIESTERASES: MOLECULAR REGULATION TO CLINICAL USE.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 3. P. 488-520 | 170 | 69% | 805 |
3 | FRANCIS, SH , BLOUNT, MA , CORBIN, JD , (2011) MAMMALIAN CYCLIC NUCLEOTIDE PHOSPHODIESTERASES: MOLECULAR MECHANISMS AND PHYSIOLOGICAL FUNCTIONS.PHYSIOLOGICAL REVIEWS. VOL. 91. ISSUE 2. P. 651 -690 | 222 | 56% | 167 |
4 | OMORI, K , KOTERA, J , (2007) OVERVIEW OF PDES AND THEIR REGULATION.CIRCULATION RESEARCH. VOL. 100. ISSUE 3. P. 309-327 | 138 | 82% | 324 |
5 | FRANCIS, SH , TURKO, IV , CORBIN, JD , (2001) CYCLIC NUCLEOTIDE PHOSPHODIESTERASES: RELATING STRUCTURE AND FUNCTION.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 65. VOL. 65. ISSUE . P. 1 -52 | 195 | 68% | 339 |
6 | BURNOUF, C , PRUNIAUX, MP , (2002) RECENT ADVANCES IN PDE4 INHIBITORS AS IMMUNOREGULATORS AND ANTI-INFLAMMATORY DRUGS.CURRENT PHARMACEUTICAL DESIGN. VOL. 8. ISSUE 14. P. 1255 -1296 | 176 | 84% | 98 |
7 | TORPHY, TJ , (1998) PHOSPHODIESTERASE ISOZYMES - MOLECULAR TARGETS FOR NOVEL ANTIASTHMA AGENTS.AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 157. ISSUE 2. P. 351 -370 | 168 | 70% | 490 |
8 | AZEVEDO, MF , FAUCZ, FR , BIMPAKI, E , HORVATH, A , LEVY, I , DE ALEXANDRE, RB , AHMAD, F , MANGANIELLO, V , STRATAKIS, CA , (2014) CLINICAL AND MOLECULAR GENETICS OF THE PHOSPHODIESTERASES (PDES).ENDOCRINE REVIEWS. VOL. 35. ISSUE 2. P. 195 -233 | 211 | 48% | 20 |
9 | SCHRODER, S , WENZEL, B , DEUTHER-CONRAD, W , SCHEUNEMANN, M , BRUST, P , (2016) NOVEL RADIOLIGANDS FOR CYCLIC NUCLEOTIDE PHOSPHODIESTERASE IMAGING WITH POSITRON EMISSION TOMOGRAPHY: AN UPDATE ON DEVELOPMENTS SINCE 2012.MOLECULES. VOL. 21. ISSUE 5. P. - | 127 | 82% | 0 |
10 | MAURICE, DH , KE, HM , AHMAD, F , WANG, YS , CHUNG, J , MANGANIELLO, VC , (2014) ADVANCES IN TARGETING CYCLIC NUCLEOTIDE PHOSPHODIESTERASES.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 4. P. 290 -314 | 116 | 48% | 120 |
Classes with closest relation at Level 1 |